With the rapid transformation and the global growth of clinical trials, controlling the cost and achieving more effective investment of the resources that small startups and biotech companies have, has been a major reason for leveraging Latin America for clinical research. Dr Martin Hernandez-Torre of Cohortias discusses the initiative of creating opportunities for clinical research in regions that have had a very minimal participation in these projects in the past.